
Recent developments in chimeric antigen receptor (CAR) T-cell therapy have shown promise in treating relapsed B-cell acute lymphoblastic leukemia in children.

Recent developments in chimeric antigen receptor (CAR) T-cell therapy have shown promise in treating relapsed B-cell acute lymphoblastic leukemia in children.

Published: January 1st 2019 | Updated: